GRIFOLS
Blood & Organ Banks · Spain · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Avinguda De La Generalitat Sant Cugat De...Phone Number
+34 935712200Website
www.grifols.comRevenue
$7 BillionStock Symbol
GRFIndustry
ZI Rank: 31
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
33
29
20
26
46
31
About GRIFOLS
Grifols is becoming increasingly global. A diverse team will remain a key component to our future success. Do you want to know more about one of the leading healthcare companies? Here you will find all the information about Grifols and our commitment to improving the health and well-being of people around world. We are a global healthcare company founded in Barcelona, Spain. Since 1940, we have been committed to improving the health and well-being of people around the world. We are an industry leader in producing plasma-derived medicines for patients around the world. Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies. We sell our products and services in more than 100 countries and have subsidiaries in 30. We aim to be a global leader in our markets and an industry reference for quality, safety and innovation. Grifols' history of growth demonstrates its capacity to evolve and make a positive impact on society. We take great pride in our etRead more
GRIFOLS Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GRIFOLS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on GRIFOLS recently announced quarterly report
Click to see if GRIFOLS had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at GRIFOLS
GRIFOLS, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when GRIFOLS launches new products
Check if GRIFOLS has recently received funding, and reach out quickly before it becomes old news!
Check out if GRIFOLS is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once GRIFOLS has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to GRIFOLS
Compare insights from companies similar to GRIFOLS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
GRIFOLS
$7B
10K+
Public
-
2019
MR
Marilyn RosaChief Medical Officer & Global Senior VP, Plasma Quality & Regulatory Affairs
$11.3B
10K+
Public
-
1931
Cecilia SorianoGroup President, Infusion Therapies Technologies & Pharmaceuticals
Company Profile Activity
Activity Insights
GRIFOLS is experiencing low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
GRIFOLS is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about GRIFOLS.
GRIFOLS Tech Stack
A closer look at the technologies used by GRIFOLS
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
GRIFOLS News & Media
Intravenous Solutions Market Booming with Rapid Growth Through 2033 | Grifols, S.A., Fresenius Kabi USA, LLC
intravenous solutions market is estimated to be valued at USD 11.77 Bn in 2026 and is expected to exhibit a CAGR of 6.5% during the forecast period (2026-2033) BURLINGAME, CA, UNITED STATES, May 21, 2026 /EINPresswire.com/ -- The latest research study …Grifols’ Canadian licence restricted after plasma donor deaths
Health Canada previously said that its investigation so far has not linked the plasma collection process and the fatalitiesGrifols to testify in House of Commons amid plasma safety scrutiny
Mary Hughes, Grifols’ vice-president of sales in Canada, is due to testify before a health committee on March 26 in OttawaGrifols secures new revolving credit facility of around $2 billion | The Corner
Link Securities | The company has received financing commitments from a syndicate of international banks for a new revolving credit facility (RCF) of
Read more news
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding GRIFOLS
Sign Up For FreeTo access detailed company insights
Grifols is becoming increasingly global. A diverse team will remain a key component to our future success. Do you want to know more about one of the leading healthcare companies? Here you will find all the information about Grifols and our commitment to improving the health and well-being of people around world. We are a global healthcare company f... Read More
